Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474).

Chiuten DF, Bennett JM, Creech RH, Glick J, Falkson G, Brodovsky HS, Begg CB, Muggia FM, Carbone PP.

Cancer Treat Rep. 1979 Jan;63(1):7-11.

PMID:
369693
2.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
3.

The epipodophyllotoxin derivatives VM-26 and VP-16-213, 1976-1979, a review.

Nissen NI, Dombernowsky P, Hansen HH, Pedersen AG.

Recent Results Cancer Res. 1980;74:98-106. Review.

PMID:
7003663
4.

VM 26 and VP 16-213: a comparative analysis.

Rozencweig M, Von Hoff DD, Henney JE, Muggia FM.

Cancer. 1977 Jul;40(1):334-42. Review.

Supplemental Content

Support Center